It has been reported that aSMase-deficient mice show a broad range of abnormalities in the central nervous system193, and aSMase can modulate autophagic processes in Alzheimer’s disease by modulating lysosomal biogenesis194. This evidence concerns the gene SMPD1 and Alzheimer disease.